Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry-Reference-Cited by-同舟云学术

Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry

Published:2021-06-21 Issue:7 Volume:49 Page:652-663
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin Experiment Ophthalmol

Author:

Nguyen Vuong¹^ORCID,Barthelmes Daniel¹²,Gillies Mark C.¹

Affiliation:

1. Discipline of Ophthalmology, Sydney Medical School The University of Sydney, Save Sight Institute Sydney New South Wales Australia

2. Department of Ophthalmology, University Hospital Zurich University of Zurich Zurich Switzerland

Funder

Macular Disease Foundation Australia

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.13949

Reference89 articles.

1. Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables

2. Using Genetic Variation and Environmental Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration

3. Field Trials of Health Interventions

4. The use of real-world evidence for evaluating anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration

5. US Food and Drug Administration.Use of Real‐World Evidence to Support Regulatory Decision‐Making for Medical Devices.2017.https://www.fda.gov/media/99447/download. Accessed March 16 2021.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice;Ophthalmology Retina;2024-06

2. The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma;Canadian Journal of Ophthalmology;2024-05

3. XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration;Ophthalmology and Therapy;2024-01-10

4. The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study;Russian Ophthalmological Journal;2023-12-19

5. From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema;Progress in Retinal and Eye Research;2023-11